Viewing StudyNCT00420316



Ignite Creation Date: 2024-05-05 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00420316
Status: COMPLETED
Last Update Posted: 2018-08-28
First Post: 2007-01-10

Brief Title: Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bios HRV Vaccine
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Infections Rotavirus
Keywords:
Name View
Finland View
Intussusception View
Gastroenteritis View